CN5 EXPLORATORY ECONOMIC EVALUATION OF ADJUVANT TREATMENT OF NON-SMALL-CELL LUNG CANCER (NSCLC) WITH BEVACIZUMAB IN ADDITION TO A CISPLATIN-BASED TREATMENT REGIMEN IN THE UNITED KINGDOM
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66228-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)66228-6/fulltext
Title :
CN5 EXPLORATORY ECONOMIC EVALUATION OF ADJUVANT TREATMENT OF NON-SMALL-CELL LUNG CANCER (NSCLC) WITH BEVACIZUMAB IN ADDITION TO A CISPLATIN-BASED TREATMENT REGIMEN IN THE UNITED KINGDOM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66228-6&doi=10.1016/S1098-3015(10)66228-6
First page :
Section Title :
Open access? :
No
Section Order :
64